In an ongoing effort to curb the spread of mpox in the Mile High City, the Denver Department of Public Health & Environment (DDPHE) has issued an update reminding residents that resources like testing, free vaccines, and treatment are readily available. Recognizing the persistent circulation of cases, local health authorities emphasize prevention through vaccination, the cornerstone of public health response to the outbreak.
The vaccine, known as Jynneos, is fully FDA-approved and administered in a two-dose series, 28 days apart. Despite the initial urgency, public health officials urge individuals to complete the series, even if more than a month has lapsed since the first jab. "Get your second dose even if it’s been a month or more since your first," as per DDPHE, signaling the importance of full vaccination. To accommodate preferences, the vaccine can be administered intradermally, or subcutaneously to avoid scarring.
The spread of mpox, principally through close personal and intimate contact, makes clear communication and community awareness critical. According to the DDPHE, exposure can occur via skin-to-skin contact with lesions and through saliva, snot, mucus, or even contact with contaminated materials. These transmission mechanisms, underscore the virus’ ability to proliferate within close-quarter interactions, driving the push for widespread testing and vaccination.
The city's health bulletin detailed the symptoms associated with mpox, which range from rash or bumps resembling other conditions like syphilis or acne to flu-like symptoms encompassing fever, muscle aches, and swollen lymph nodes. "People with mpox often get a rash that may be located on hands, feet, chest, face, or mouth or near the genitals, including the penis, testicles, labia, vagina, and anus," as stated by DDPHE. Given the virus’s incubation period of 3–17 days, individuals are advised to remain vigilant, as symptoms can manifest weeks after exposure.
Testing remains a pillar of the strategy to control mpox’s spread, with the DDPHE encouraging those with new rashes or bumps to seek testing regardless of vaccination status. Treatments, such as the antiviral TPOXX, are options for those who test positive. The availability of resources, paired with vigilant symptom checking and open dialogue with healthcare providers and partners, compose the multifaceted approach Denver is employing to manage mpox in its communities.
